Plain-English translation of NCT04547725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combination approach for a specific type of advanced stomach cancer. If your cancer has spread to the lining inside your abdomen (called peritoneal carcinomatosis), doctors will surgically remove as much cancer as possible, then treat you with paclitaxel—a chemotherapy drug delivered directly into your abdomen—along with systemic chemotherapy (given through your veins). The goal is to see if this combined approach can help patients live longer and healthier.
When stomach cancer spreads to the lining of the abdomen, it has traditionally been considered incurable and treated only with chemotherapy pills or infusions, which have not worked well. Recent research suggests that combining surgery to remove the cancer with direct chemotherapy into the abdomen might offer better results, and this trial aims to find out if a gentler, safer version of this approach truly helps.
You likely qualify if…
You likely don't qualify if…
You will undergo surgery to remove your stomach and as much cancer as possible from your abdomen. During surgery, your doctor will also deliver chemotherapy directly into your abdomen. After you recover, you will receive additional chemotherapy through your veins over several months. You will have blood tests and imaging scans to monitor how well the treatment is working and to watch for side effects. The trial will track your health for at least 6 months to see if the cancer comes back and how well you are doing overall.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Taiwan